End Stage Liver Disease clinical trials

Explore recruiting end stage liver disease clinical trials.

Recruiting end stage liver disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

End Stage Liver Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Effect of Resmetirom on Liver-related Outcomes in Patients with Well-compensated (Child-Pugh A) Non alcoholic Steatohepatitis (NASH) Cirrhosis (MAESTRO-NASH OUTCOMES)

Spain, Germany, France, Belgium, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2 Study to Evaluate Efficacy, Safety and Tolerability of VIR-2218 and VIR-3434 in Participants with Chronic Hepatitis D Virus Infection (SOLSTICE)

France, Romania, Netherlands, Germany, Bulgaria, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

ALBUMINUS: Dose reduction of human albumin during large-volume paracentesis in patients with cirrhosis

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Randomized, placebo-controlled, double blind, multi-centre Phase IIb stuDy to evaluate the efficacy and safety of HepaStem in patients with Acute on Chronic Liver Failure (ACLF) – DHELIVER

Denmark, Poland, Bulgaria, Netherlands, Slovakia, Latvia +8 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Austria, Italy, Czechia, Romania, Sweden, Spain +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia (BOLD-EXT)

Spain, Italy, Germany, Poland, Hungary, France +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

End Stage Liver Disease trials by city

End Stage Liver Disease in Toronto End Stage Liver Disease in Vancouver End Stage Liver Disease in Montreal End Stage Liver Disease in Calgary End Stage Liver Disease in Edmonton End Stage Liver Disease in Ottawa End Stage Liver Disease in Winnipeg End Stage Liver Disease in Quebec City End Stage Liver Disease in Hamilton End Stage Liver Disease in Kitchener End Stage Liver Disease in London End Stage Liver Disease in Halifax End Stage Liver Disease in New York End Stage Liver Disease in Los Angeles End Stage Liver Disease in Chicago End Stage Liver Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease